Lithium Australia moves forward with large-scale pilot plant


Published 08-MAR-2018 11:19 A.M.


3 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

Lithium Australia NL (ASX:LIT), a small-cap looking to mine lithium as well as establish a vertically integrated lithium processing business, is undertaking the final steps towards getting its large-scale pilot plant up and running.

At this stage, as the company finishes its front-end engineering and design studies, it is also assessing feed sources for the first 12 months of operation.

LIT’s SiLeach® is a lithium processing technology that efficiently digests and recovers all significant metal values from ore. It can be applied to a wide range of lithium feedstock, with low energy consumption and high rates of metal recoveries.

The company’s recent acquisition of VSPC (Very Small Particle Company) provided LIT with access to the most advanced cathode-powder production technology. The application of VSPC’s technology could result in LIT being able to control the supply chain from waste material through to cathode powder, a unique advantage over competitors.

The pilot plant process will take waste products, in particular low-grade lepidolite mica feedstock, and turn it into lithium chemicals through SiLeach® technology. LIT is looking to expedite the process to get the pilot plant online as soon as possible, and produce advanced cathode powders which major battery manufacturers require to make lithium-ion batteries.

However, this remains a speculative stock and investors considering this stock for their portfolio, should seek professional financial advice.

Feed sources

A potential feed source (lithium mica) which LIT is exploring is material from the Lepidolite Hill lithium deposit, located approximately 520 kilometres east of Perth. The site is part of the Coolgardie Rare Metals Venture, an initiative of Lithium Australia (80%) and ASX-listed Focus Minerals Limited (ASX: FML) (20%).

Lepidolite Hill has been the subject of recent innovative beneficiation testwork. The below comparison shows the beneficiated product from the site, and the rejected materials:

Lithium australia ore sorting results

TOMRA Sorting Solutions were engaged to carry out the testwork on bulk samples obtained from dumps surrounding the historic mine workings at Lepidolite Hill. The ore-sorting tests indicate the possibility of rejecting a large proportion of the waste material, which would result in a reduction of the required capacity of the ore-preparation section of the pilot plant.

The material newly recovered by the above ore-sorting is now being assayed and mass balances calculated, with further comminution and flotation tests planned for the beneficiated product.

At the same time, similar lepidolite occurrences in Western Australia are also being investigated by LIT.

Managing Director Adrian Griffin commented on today’s announcement: “Lithium Australia is striving to improve the sustainability of the energy-metal sector. Recovery of lithium from mine waste is a great example of that, and we are strongly focused on opportunities in both Europe and Western Australia.

“As demand for lithium grows, efficient resource utilisation will become essential. Our range of technologies allows us to seize opportunities as they arise, and that includes more than merely accessing mine waste – we’re also developing the ability to rebirth used lithium-ion batteries. It’s all part of Lithium Australia’s plan to take greater responsibility for the stewardship of our finite resources.”

lithium australia pilot plant

The SiLeach® process.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free